Citations

Clear

16280 citation(s) found for "Yu, David".

Imaging-based Surgical Site Infection Detection Using Artificial Intelligence
Muaddi, Hala , Anderson, Stephanie , Etzioni, David A. , McLaughlin, Sarah A. , Kendrick, Michael L. , Salehinejad, Hojjat , Anderson, Stephanie S., Etzioni, David, Kendrick, Michael, Choudhary, Ashok, Lee, Frank, Habermann, Elizabeth B. , Thiels, Cornelius A.

Mayo Clinic

Annals of Surgery | July 3, 2025 | Volume: 282 | Issue: 3 | Pages: 419-428

10.1097/sla.0000000000006826 | PMID 40607706 Get It

Objective: To develop an artificial intelligence–based pipeline to assess and triage patient-submitted postoperative wound images. Background: The rise of outpatient surgeries, remote monitoring, and patient-submitted wound images via online portals has contributed to a growing administrative workload on clinicians. Early identification of surgical site infection (SSI) is essential for reducing postoperative morbidity. Methods: Patients ≥18 years old who underwent surgery at 9 affiliated Mayo Clinic hospitals (2019-2022) and were captured by the National Surgical Quality Improvement Program (NSQIP) were included. Eligibility required submission of one image via the patient portal within 30 days after surgery. Images were independently screened in duplicate to determine the presence of an incision. SSI outcomes were obtained from NSQIP. The developed model consisted of 2 stages: incision detection and SSI detection in images with incisions. Four pretrained architectures were evaluated using 10-fold cross-validation, with upsampling and data augmentation to mitigate class imbalance. An end-to-end pipeline, image quality assessment and sensitivity analysis stratified by race were also performed. Results: Among 6060 patients, the median age was 54 years (interquartile range: 40–65), 61.4% (n=3805) were female, and 92.5% (n=5731) identified as White. SSIs were confirmed in 6.2% (n=386) images. Vision Transformer outperformed all others, achieving an incision detection accuracy of 0.94 (area under the curve=0.98) and an SSI detection accuracy of 0.73 (area under the curve=0.81). In addition, it demonstrated strong performance in assessing image quality. Sensitivity analysis revealed comparable performance across racial subgroups. Conclusion: This artificial intelligence pipeline demonstrates promising performance in automating wound image assessment and SSI detection, reducing clinical workload and improving postoperative care.
Determination of core knowledge and skills for Pediatric Rehabilitation Medicine certification: A systematic practice analysis
Murphy, Kevin P. , Apkon, Susan , Raddatz, Mikaela M. , Kassam, Siddiq, Driscoll, Sherilyn W. , Kinney, Carolyn L. , Pruitt, David W.

Mayo Clinic

Journal of Pediatric Rehabilitation Medicine | July 3, 2025 | Volume: 18 | Issue: 3 | Pages: 230-243

10.1177/18758894251353067 | PMID 40605633 Get It

Purpose: In 2022, the American Board of Physical Medicine and Rehabilitation (ABPMR) contracted with Professional Services Industries LLC to complete a Pediatric Rehabilitation Medicine (PRM) practice analysis. The goal was to develop an updated examination content outline that accurately depicts the knowledge and skills expected for a competent PRM physician following completion of training. The purpose of this paper is to describe the process of practice analysis and to present candidate perceptions of scope of practice and relevancy of content from the first two examinations in which the new outline was applied. Methods: The practice analysis process was undertaken in four distinct stages: subject matter expert meetings to determine the tasks and knowledge areas; the development, issuance and analysis of a national survey; development of exam specifications; and results verification. Results were analyzed by a psychometrician and team to determine mean relative importance of task and knowledge items. A new outline was then created and used for the administration of the 2023 and 2024 ABPMR PRM Certification Examinations. Results: All active board certified PRM physicians identified were sent surveys via e-mail. One hundred ninety six (61.1%) respondents completed the survey. The top five task statements in order of perceived importance were performing history and physical examinations, managing muscle and tone abnormalities, prescribing orthoses and equipment, prescribing therapy services, and making appropriate specialty care referrals. The top five knowledge statements in order of perceived importance were cerebral palsy, spinal cord injury, abnormal growth and development, neuromuscular disorders, and musculoskeletal conditions. The new PRM Examination content outline created included six domains and 22 subdomains of knowledge content areas. A higher percentage of initial certification candidates sitting for the 2023 and 2024 ABPMR PRM Certification Examinations selected “Strongly Agree” or “Agree” when responding to the examination content reflecting both scope of training and relevancy. Conclusion: A practice analysis process was undertaken resulting in a new content outline for the ABPMR PRM Certification Examination. Following the implementation of the new content outline, initial certification candidate survey responses showed improved favorability regarding content reflecting scope of training and relevancy.
Who Reconstitutes the Chemotherapy? The Educational and Practice Needs of Oncology Pharmacists in West Africa: A Call for Multidisciplinary Team Approach in Oncology Care
Chidebe, Runcie C.W. , Alabelewe, Ramatu Masud, Sapkota, Krishna Prasad , Esiaka, Darlingtina , Okwu, Gloria C., Emejulu, Jacinta, Umar, Adamu Abubakar , Okwuegbunam, Ndifreke, David, Funsho, Adepoju, Toyosi, Agha, Agha A., Ugwu, Ejike, Aruah, Simeon Chinedu , Duncombe, Rob, Wannang, Noel N., O’Bryant, Cindy L. , Esiaka, Darlingtina K , Aruah, Simeon C , Babalola, Peace C , Harvey, R Donald , O'Bryant, Cindy , Odedina, Folakemi , Nwakasi, Candidus C. , Umar, Adamu A., Mshelia, Richard, Harvey, R. Donald

Mayo Clinic

JCO Global Oncology | July 1, 2025 | Volume: No volume available | Issue: 11 | Pages: No page available

10.1200/go-25-00021 | PMID 40591900 Get It

PURPOSE Oncology pharmacists (OPs) play a crucial role in cancer care, treatment, survivorship, and multidisciplinary teams (MDTs). OPs have specialized training in designing, administering, monitoring, and modifying oncology chemotherapy; managing adverse events; and evaluating clinical trials and investigational drugs. Yet, the state of OP has remained largely unknown in the clinical oncology workforce of the West African region. Therefore, this study aimed to understand who reconstitutes chemotherapy and to explain the OP educational and practice needs, challenges, and solutions in Nigeria. MATERIALS AND METHODS Using a concurrent embedded mixed method design, 35 OPs completed a questionnaire, and 12 others responded to a semistructured interview. The data were then subjected to inductive thematic and descriptive analyses. RESULTS The findings showed that 54% of the OPs were responsible for chemotherapy reconstitution, and only 60% of the oncology centers had a biosafety cabinet. 91% of OPs were practicing; however, only 54% were trained in OP, and none of the OPs were board-certified. Most of the OPs spent time weekly on reconstitution, administrative duties, teaching, and training; only 3% spent on oncology clinical trials and conferences and 8% on noninterventional research. We identified four themes: (1) Some OPs are not reconstituting chemotherapy: A Call for MDT, (2) For OP, No Training is Enough, (3) Board Certification will give OPs Recognition, and (4) Introduction of OP Course in Universities. CONCLUSION To improve patient treatment outcomes, training on chemotherapy reconstitution should be prioritized, integration of OPs into MDTs, and the safe handling of chemotherapy in centers should be mandated in the region. The West African Postgraduate College of Pharmacists should be supported in expanding its curriculum and introducing OP fellowships.
Specific overexpression of contactin-associated protein-like 2 and its effects on pain-related behaviour in mice
Tseng, Mandy , Farah, Adham , Irani, Sarosh R. , Dawes, John M. , Dawes, John M , Irani, Sarosh R , Middleton, Steven J. , Bennett, David

Mayo Clinic

PAIN Reports | July 1, 2025 | Volume: 10 | Issue: 4 | Pages: e1309

10.1097/pr9.0000000000001309 | PMID 40584936 Get It

Abstract Introduction: Hyperexcitability, particularly of DRG neurons, is a key driver of persistent pain states including neuropathic pain. Contactin-associated protein-like 2 (CASPR2) is transmembrane protein known to interact and regulate the function of Kv1 channels, important determinants of neuronal excitability. Patients with autoantibodies (-Abs) against CASPR2 commonly have neuropathic pain, and these patient-Abs enhance the excitability of DRG neurons secondary to Kv1 channel disruption, leading to pain-related hypersensitivity. This is also observed after genetic ablation of CASPR2. Conversely, increasing CASPR2 levels in DRG neurons reduces excitability. Objectives: The aim of this study was to assess whether overexpressing CASPR2 could be a potential approach to treat pain. Methods: We generated a Cre-dependent mouse line to express human CASPR2 (R26 LSL:hCNTNAP2(+/+) (CASPR2 OE )) and crossed this with either Hoxb8 Cre or Nav1.8 Cre mice for CASPR2 overexpression in either all DRG neurons or to target nociceptors more selectively. Results: In both lines, CASPR2 was significantly overexpressed in DRG neurons, including at the cell membrane. In comparison to control littermates, overexpression of CASPR2 did not affect acute pain–related behaviour to mechanical or thermal stimulation or nerve injury–induced pain-related hypersensitivity. However, in both overexpression mouse lines, there were significantly reduced nocifensive responses to capsaicin. Although CASPR2 overexpression increased the contribution of α-dendrotoxin–sensitive Kv1 channels to the slowly inactivating outward current I KD , it did not affect total I KD. Conclusion: CASPR2 overexpression in DRG neurons can affect nociception, reducing pain-related behaviours to the noxious stimulant capsaicin, yet is insufficient to reduce mechanical pain–related hypersensitivity caused by nerve injury.
From CyBorD to dara-CyBorD, ASCT utilization trends in AL amyloidosis: a 15-year analysis
Muchtar, Eli , Buadi, Francis K. , Kapoor, Prashant , Dingli, David , Kourelis, Taxiarchis , Leung, Nelson , Hayman, Suzanne R. , Lacy, Martha Q. , Abdallah, Nadine , Binder, Moritz , Zanwar, Saurabh , Warsame, Rahma , Kumar, Shaji , Dispenzieri, Angela , Buadi, Francis K , Kourelis, Taxiarchis , Leung, Nelson , Lacy, Martha Q , Siddiqui, Mustaqeem A , Cook, Joselle M , Abdallah, Nadine H , Zanwar, Saurabh S , Hogan, William J , Warsame, Rahma , Kumar, Shaji K , Gertz, Morie A , Muchtar, E , Binder, Moritz , Dingli, David , Dispenzieri, Angela , Gonsalves, Wilson I. , Siddiqui, Mustaqeem , Cook, Joselle , Hogan, William J. , Rajkumar, S. Vincent , Gertz, Morie A.

Mayo Clinic

Blood Advances | July 1, 2025 | Volume: 9 | Issue: 16 | Pages: 4311-4316

10.1182/bloodadvances.2025016586 | PMID 40590881 Get It

Abstract This retrospective analysis examined 15 years of autologous stem cell transplantation (ASCT) for light chain (AL) amyloidosis at the Mayo Clinic (2010-2024). We aimed to assess ASCT utilization trends, factors influencing practice changes, and current indications amid newer therapies. Four hundred and forty-one ASCTs were divided into cohort 1 (2010-2019) and cohort 2 (2020-2024), revealing a significant ASCT reduction in cohort 2 (385 vs 56, average 71% annual decrease). Cohort 2 patients were older, more likely to have relapsed/refractory disease, and had higher baseline bone marrow plasma cell burden compared to cohort 1. Pre-ASCT induction was more frequent in cohort 2 (89.3% vs 56.4%), with daratumumab (Dara)–cyclophosphamide-bortezomib-dexamethasone (CyBorD) replacing CyBorD as the predominant induction regimen. Lymphoma-based regimens were also more common in cohort 2 (15.1% vs 5.3%, P = .02). Day-100 satisfactory hematological response improved in cohort 2 (91.1% vs 72.7%, P = .001), although hematological complete response rates did not significantly differ (50.9% vs 38.8%, P = .09). In summary, there is a decrease in the utilization of ASCT in AL amyloidosis. This procedure is primarily reserved for patients with suboptimal responses, relapsed/refractory disease, lymphoplasmacytic clones (predominantly immunoglobulin M amyloidosis), or high bone marrow plasma cell burden (myeloma phenotype). This study underscores a significant shift in ASCT practice, driven by novel therapies, emphasizing more personalized management in AL amyloidosis.
Early Stages of Automated Insulin Delivery
Zisser, Howard , Hovorka, Roman , Basu, Ananda , Battelino, Tadej , Boughton, Charlotte K. , Breton, Marc D. , Buckingham, Bruce A. , Brown, Sue A. , Cherñavvsky, Daniel R. , Dassau, Eyal , Ekhlaspour, Laya , Forlenza, Gregory P. , Haidar, Ahmad , Klonoff, David C. , Kovatchev, Boris , Kowalski, Aaron J. , Kudva, Yogish C., Maahs, David M. , Phillip, Moshe , Russell, Steven J. , Steil, Garry M. , Weinzimer, Stuart A. , Doyle, Francis J , Ekhlaspour, Laya , Fabris, Chiara , Forlenza, Gregory P , Klonoff, David C , Kovatchev, Boris , Levy, Carol J , Maahs, David M , Phillip, Moshe , Renard, Eric , Russell, Steven J , Shah, Viral N , Wadwa, R Paul , Battelino, Tadej , Hovorka, Roman , Buckingham, Bruce , DeBoer, Mark Daniel , Doyle, Francis J. , Levy, Carol J. , Kudva, Yogish C. , Shah, Viral N.

Mayo Clinic

Diabetes Technology & Therapeutics | July 1, 2025 | Volume: 27 | Issue: 3_suppl | Pages: No page available

10.1089/dia.2025.18802.hz | PMID 40590745 Get It

The development of automated insulin delivery systems has seen tremendous improvements from individual components to interoperable system combinations of devices and new drugs besides insulin. The components have become progressively smaller, more accurate, and more user friendly. This article summarizes the history of the artificial pancreas from the earliest concepts to fully functional systems to research into further improvements in the future. The authors include many of the developers of this technology who received research support from the National Institute of Diabetes and Digestive and Kidney Diseases at various stages to develop these systems.
Early Stages of Automated Insulin Delivery
Zisser, Howard , Hovorka, Roman , Basu, Ananda , Battelino, Tadej , Boughton, Charlotte K. , Breton, Marc D. , Buckingham, Bruce A. , Brown, Sue A. , Cherñavvsky, Daniel R. , Dassau, Eyal , Ekhlaspour, Laya , Forlenza, Gregory P. , Haidar, Ahmad , Klonoff, David C. , Kovatchev, Boris , Kowalski, Aaron J. , Kudva, Yogish C. , Maahs, David M. , Phillip, Moshe , Russell, Steven J. , Steil, Garry M. , Weinzimer, Stuart A. , Doyle, Francis J , Ekhlaspour, Laya , Fabris, Chiara , Forlenza, Gregory P , Klonoff, David C , Kovatchev, Boris , Levy, Carol J , Maahs, David M , Phillip, Moshe , Renard, Eric , Russell, Steven J , Shah, Viral N , Wadwa, R Paul , Battelino, Tadej , Hovorka, Roman , Buckingham, Bruce , DeBoer, Mark Daniel , Doyle, Francis J. , Levy, Carol J. , Shah, Viral N.

Mayo Clinic

Journal of Diabetes Science and Technology | July 1, 2025 | Volume: 19 | Issue: 4 | Pages: 908-923

10.1177/19322968251335685 | PMID 40590463 Get It

The development of automated insulin delivery systems has seen tremendous improvements from individual components to interoperable system combinations of devices and new drugs besides insulin. The components have become progressively smaller, more accurate, and more user friendly. This article summarizes the history of the artificial pancreas from the earliest concepts to fully functional systems to research into further improvements in the future. The authors include many of the developers of this technology who received research support from the National Institute of Diabetes and Digestive and Kidney Diseases at various stages to develop these systems.
GRADE Certainty Ratings: Thresholds Rather Than Categories of Contextualization (GRADE Guidance 41)
Hultcrantz, Monica , Schünemann, Holger J. , Rind, David M., Tovey, David , Alper, Brian S. , Akl, Elie A. , Saif‐Ur‐Rahman, KM , Sousa‐Pinto, Bernardo , Mustafa, Reem A , Mayer, Martin , Tovey, David , Alper, Brian S , Akl, Elie A , Saif-Ur-Rahman, K M , Schünemann, Holger J , Murad, M. Hassan , Neumann, Ignacio , Izcovich, Ariel , Guyatt, Gordon

Mayo Clinic

Annals of Internal Medicine | June 30, 2025 | Volume: 178 | Issue: 8 | Pages: 1183-1186

10.7326/annals-25-00548 | PMID 40587852 Get It